Evidence map›Paper›PMID 32884775›Full record

ArticleClinical case reports2020

Terminal deletion of chromosome 13 in a fetus with normal NIPT: The added value of invasive prenatal diagnosis in the NIPT era.

Evy Vervecken, Bettina Blaumeiser, Tina Vanderheyden, Jan Hauspy, Katrien Janssens

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Prenatal Sonographic Features of Rare Chromosome 13 Aberrations.The application of clinical genetics · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Evy VerveckenDepartment of Obstetrics and Gynaecology GZA Hospitals St. Augustinus Wilrijk Belgium.ORCID https://orcid.org/0000-0002-6851-5217
Bettina BlaumeiserCenter of Medical Genetics University Hospital and University of Antwerp Antwerp Belgium.ORCID https://orcid.org/0000-0001-9993-7319
Tina VanderheydenDepartment of Obstetrics and Gynaecology GZA Hospitals St. Augustinus Wilrijk Belgium.
Jan HauspyDepartment of Obstetrics and Gynaecology GZA Hospitals St. Augustinus Wilrijk Belgium.
Katrien JanssensCenter of Medical Genetics University Hospital and University of Antwerp Antwerp Belgium.
GZA Ziekenhuizen Campus Sint-Augustinus · BEUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the age of noninvasive prenatal testing, there is still an important role for invasive prenatal diagnosis, even for chromosomes 13, 18, and 21.

Indexed as

amniocentesisdeletion chromosome 13holoprosencephalyinvasive prenatal diagnosisNIPTnoninvasive prenatal test

Identifiers

PMID32884775
PMCPMC7455455
OpenAlexW3024273360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.